Sign up for free insights newsletter
25

Zhejiang Taimei Med Tech Co

2576Hong Kong Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

HK$4.71
+0.64%
End of day
Market Cap

$2.71B

P/E Ratio

N/A

Employees

656

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino2.46-1.748.291.250.382.05
Calmar-6.1123.051.250.444.58
Sharpe0.98-1.193.950.780.260.99
Omega1.510.781.771.181.111.24
Martin47.73-12.7166.852.310.7715.73
Ulcer0.252.762.0512.7816.589.73

Zhejiang Taimei Med Tech Co (2576) Price Performance

Zhejiang Taimei Med Tech Co (2576) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at HKD4.71, up 0.64% from the previous close.

Over the past year, 2576 has traded between a low of HKD3.10 and a high of HKD5.24. The stock has gained 18.9% over this period. It is currently 10.1% below its 52-week high.

Zhejiang Taimei Med Tech Co has a market capitalization of $2.71B.

About Zhejiang Taimei Med Tech Co

Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders; PharmaOS, a pharmaceutical digital marketing platform; and Enterprise-Medical Academic Interaction Platform, an enterprise-medical communication. It also provides software solutions, such as eCollect, an electronic data capture system; eCooperate, a clinical trial project management system; eBalance, a supply manage system; eArchives, a clinical trial document management system; and eCollege, a training management system; and eklmage medical imaging evalution system, EMS site management system, and paylite financial management system. In addition, the company offers trial partner digital SMO services, IRC independent review center solution, eSAE clinical trial safety information management system; eSite Pro clinical trial management platform, eTrialPro research ward management system, GCP-X intelligent clinical trial platform, IIT-EDC research data collection system; eMonitoring(iRMS) intelligent remote monitoring system, IDS investigational drug services; iDCT intelligent decentralized clinical trial; eScreening subject information management system; eSafety Pharmacovigilance Compliance Management System, eSAE Clinical Trial Safety Information Management System; ONECEM-SFE Sales Force Effectiveness, ONECEM-SCRM Intelligent Marketing System, ONECEM-Event+Engagement; and ONEInsight Marketing Data Platform. Zhejiang Taimei Medical Technology Co., Ltd.was founded in 2013 and is headquartered in Jiaxing, China.

Company Info

Exchange
Hong Kong Stock Exchange
Currency
HKD
Country
Hong Kong

Financial Metrics

Revenue (TTM)
$522.59M
EBITDA
$-86,445,000
Profit Margin
-12.68%
EPS (TTM)
-0.04
Book Value
2.29

Technical Indicators

52 Week High
HK$5.31
52 Week Low
HK$3.06
50 Day MA
HK$4.68
200 Day MA
HK$4.29
Beta
N/A

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
5.18
Price/Book
2.07
Enterprise Value
$1.41B